S&P 50 · Free
Abbott Laboratories
ABT#MedicalDevicesHigh stock comp
Abbott Laboratories trades at 18.11x forward earnings — In line with peers (vs 19 peers in #MedicalDevices). Price $110.37.
- Forward P/E
- 18.11
- Industry median 17.41
- Current P/E
- 20.98
- Industry median 19.73
- Forward PEG
- 1.83
- Next fiscal year
- Opportunity Score
- 49
- Neutral
Forward P/Edivides today's price by the earnings analysts expect Abbott Laboratories to make over the next fiscal year — see what forward P/E measures for the full definition. Opportunity Score is a separate, slower 0–100 read on how attractive today looks as a historical entry point — see how it's built.
Consensus earnings run well above GAAP earnings, mostly through stock-based compensation. Ordinary for high-growth software, but it dilutes shareholders and makes any single earnings multiple a weaker signal.